Characterization of the Inflammatory Response to Severe COVID-19 Illness
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Abstract Rationale Coronavirus disease (COVID-19) is a global threat to health. Its inflammatory characteristics are incompletely understood. Objectives To define the cytokine profile of COVID-19 and to identify evidence of immunometabolic alterations in those with severe illness. Methods Levels of IL-1β, IL-6, IL-8, IL-10, and sTNFR1 (soluble tumor necrosis factor receptor 1) were assessed in plasma from healthy volunteers, hospitalized but stable patients with COVID-19 (COVIDstable patients), patients with COVID-19 requiring ICU admission (COVIDICU patients), and patients with severe community-acquired pneumonia requiring ICU support (CAPICU patients). Immunometabolic markers were measured in circulating neutrophils from patients with severe COVID-19. The acute phase response of AAT (alpha-1 antitrypsin) to COVID-19 was also evaluated. Measurements and Main Results IL-1β, IL-6, IL-8, and sTNFR1 were all increased in patients with COVID-19. COVIDICU patients could be clearly differentiated from COVIDstable patients, and demonstrated higher levels of IL-1β, IL-6, and sTNFR1 but lower IL-10 than CAPICU patients. COVID-19 neutrophils displayed altered immunometabolism, with increased cytosolic PKM2 (pyruvate kinase M2), phosphorylated PKM2, HIF-1α (hypoxia-inducible factor-1α), and lactate. The production and sialylation of AAT increased in COVID-19, but this antiinflammatory response was overwhelmed in severe illness, with the IL-6:AAT ratio markedly higher in patients requiring ICU admission (P < 0.0001). In critically unwell patients with COVID-19, increases in IL-6:AAT predicted prolonged ICU stay and mortality, whereas improvement in IL-6:AAT was associated with clinical resolution (P < 0.0001). Conclusions The COVID-19 cytokinemia is distinct from that of other types of pneumonia, leading to organ failure and ICU need. Neutrophils undergo immunometabolic reprogramming in severe COVID-19 illness. Cytokine ratios may predict outcomes in this population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016 · cited 1×
“studies have described a proinflammatory syndrome with a disproportionately high rate of progression to acute respiratory distress syndrome (ARDS), acute renal failure, shock, and arrhythmia (3, 4).”
BackgroundWu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · cited 1×
“As the transcription factor driving both LDH and PDK, HIF-1a dictates the fate of pyruvate and holds the key to cellular metabolic balance (37).”
BackgroundItaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
Mills, E. L., Ryan, D. G., Prag, H. A., Dikovskaya, D., Menon, D., Zaslona, Z., Jedrychowski, M. P., Costa, A. S. H., Higgins, M., Hams, E., et al. (2018) · Nature · doi:10.1038/nature25986 · Cited by 1,885 · cited 1×
“Other potential strategies, such as the maintenance of PKM2 in a tetramer conformation by molecules such as TEPP-46 (5) or the use of itaconate as an antiinflammatory and antioxidant (39) hold promise but have yet to progress to the clinical arena.”
BackgroundSelf-citationPyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
Palsson-McDermott, E. M., Curtis, A. M., Goel, G., Lauterbach, M. A. R., Sheedy, F. J., Gleeson, L. E., van den Bosch, M. W. M., Quinn, S. R., Domingo-Fernandez, R., Johnston, D. G. W., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.005 · Cited by 1,397
COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome
Gattinoni, L., Coppola, S., Cressoni, M., Busana, M., Rossi, S., & Chiumello, D. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0817le · Cited by 1,396
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.333 · Cited by 1,173
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study
Du, Y., Tu, L., Zhu, P., Mu, M., Wang, R., Yang, P., Wang, X., Hu, C., Ping, R., Hu, P., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202003-0543oc · Cited by 942
HIF1α and metabolic reprogramming in inflammation
Corcoran, S. E., & O’Neill, L. A. J. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84431 · Cited by 776
Succinate: a metabolic signal in inflammation
Mills, E., & O’Neill, L. A. J. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.11.008 · Cited by 741 · cited 2×
“Symptoms at admission Fever 17 (85) 18 (90) 35 (88) Dyspnea 11 (55) 15 (75) 26 (65) Cough 11 (55) 14 (70) 25 (60) Sputum production 5 (25) 5 (25) 10 (25) Myalgia 8 (40) 7 (35) 15 (38) Sore throat 5 (25) 4 (20) 9 (23) Nasal congestion 1 (5) 0 (0) 1 (3) Headache 6 (30) 5 (25) 11 (28) Fatigue 13 (65) 14 (70) 13 (68) Anor…”
Neutrophil-derived cytokines: facts beyond expression
Tecchio, C., Micheletti, A., & Cassatella, M. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00508 · Cited by 699 · cited 3×
“Neutrophils were chosen for this purpose, as they produce all of the aforementioned cytokines (17, 18), were increased in the peripheral blood of COVIDICU patients, and are heavily implicated in the pathogenesis of ARDS (12), where HIFmediated signaling is upregulated (19).”
BackgroundCOVID-19 pneumonia: ARDS or not?
Gattinoni, L., Chiumello, D., & Rossi, S. (2020) · Critical Care · doi:10.1186/s13054-020-02880-z · Cited by 672
Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome.
Goodman, R. B., Strieter, R. M., Martin, D. P., Steinberg, K. P., Milberg, J. A., Maunder, R. J., Kunkel, S. L., Walz, A., Hudson, L. D., & Martin, T. R. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810593 · Cited by 526
Interleukin‐1β, Interleukin‐18, and the Interleukin‐1β Converting Enzymea
DINARELLO, C. A. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb08307.x · Cited by 498
Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study
Ziehr, D. R., Alladina, J., Petri, C. R., Maley, J. H., Moskowitz, A., Medoff, B. D., Hibbert, K. A., Thompson, B. T., & Hardin, C. C. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1163le · Cited by 455
Michelakis, E. D., Gurtu, V., Webster, L., Barnes, G., Watson, G., Howard, L., Cupitt, J., Paterson, I., Thompson, R. B., Chow, K., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aao4583 · Cited by 316
α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8
Bergin, D. A., Reeves, E. P., Meleady, P., Henry, M., McElvaney, O. J., Carroll, T. P., Condron, C., Chotirmall, S. H., Clynes, M., O’Neill, S. J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41196 · Cited by 287
Self-citationAnti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase
Jonigk, D., Al-Omari, M., Maegel, L., Müller, M., Izykowski, N., Hong, J., Hong, K., Kim, S.-H., Dorsch, M., Mahadeva, R., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309648110 · Cited by 258
Donnelly, S. C., Strieter, R. M., Reid, P. T., Kunkel, S. L., Burdick, M. D., Armstrong, I., Mackenzie, A., & Haslett, C. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-3-199608010-00005 · Cited by 255
α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood
Pott, G. B., Chan, E. D., Dinarello, C. A., & Shapiro, L. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208145 · Cited by 185
Physiological Effects of Chronic Hypoxia
West, J. B. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1612008 · Cited by 172
Bergin, D. A., Reeves, E. P., Hurley, K., Wolfe, R., Jameel, R., Fitzgerald, S., & McElvaney, N. G. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007116 · Cited by 165
Self-citationCytokine assays: An assessment of the preparation and treatment of blood and tissue samples
Keustermans, G. C. E., Hoeks, S. B. E., Meerding, J. M., Prakken, B. J., & de Jager, W. (2013) · Methods · doi:10.1016/j.ymeth.2013.04.005 · Cited by 162
Juss, J. K., House, D., Amour, A., Begg, M., Herre, J., Storisteanu, D. M. L., Hoenderdos, K., Bradley, G., Lennon, M. G., Summers, C., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201509-1818oc · Cited by 158
α1-Antitrypsin, Old Dog, New Tricks
Janciauskiene, S. M., Nita, I. M., & Stevens, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607976200 · Cited by 143
Riches, P. G., Gooding, R. P., Millar, B. C., & Rowbottom, A. W. (1992) · Journal of Immunological Methods · doi:10.1016/0022-1759(92)90314-j · Cited by 141
Fever: Links with an ancient receptor
Dinarello, C. A., Gatti, S., & Bartfai, T. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80085-2 · Cited by 109
Specific Inhibition of the NLRP3 Inflammasome as an Antiinflammatory Strategy in Cystic Fibrosis
McElvaney, O. J., Zasłona, Z., Becker-Flegler, K. A., Pålsson‐McDermott, E. M., Boland, F., Gunaratnam, C., Gulbins, E., O'Neill, L. A. J., Reeves, E. P., & McElvaney, N. G. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201905-1013oc · Cited by 102
Self-citationJoosten, L. A. B., Crișan, T. O., Azam, T., Cleophas, M. C. P., Koenders, M. I., van de Veerdonk, F. L., Netea, M. G., Kim, S., & Dinarello, C. A. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206966 · Cited by 81
Interleukin-6 expression in human neutrophil and eosinophil peripheral blood granulocytes
Melani, C., Mattia, G., Silvani, A., Care, A., Rivoltini, L., Parmiani, G., & Colombo, M. (1993) · Blood · doi:10.1182/blood.v81.10.2744.2744 · Cited by 75
Hurley, K., Lacey, N., O’Dwyer, C. A., Bergin, D. A., McElvaney, O. J., O’Brien, E., McElvaney, O. F., Reeves, E. P., & McElvaney, N. G. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400132 · Cited by 68
Self-citationO’Dwyer, C. A., O’Brien, E., Wormald, M. R., White, M. M., Banville, N., Hurley, K., McCarthy, C., McElvaney, N. G., & Reeves, E. P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500038 · Cited by 66
Self-citationGlycosylation Repurposes Alpha-1 Antitrypsin for Resolution of Community-acquired Pneumonia
McCarthy, C., Dunlea, D. M., Saldova, R., Henry, M. A., Meleady, P., McElvaney, O. J., Marsh, B. J., Rudd, P. M., Reeves, E. P., & McElvaney, N. G. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201709-1954le · Cited by 42
Self-citationO’Brien, E., Fee, L. T., Browne, N., Carroll, T. P., Meleady, P., Henry, M. A., McQuillan, K., Murphy, M. P., Logan, M., McCarthy, C., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2019-214076 · Cited by 34
Self-citationBronchoalveolar fluid and plasma inflammatory biomarkers in contemporary ARDS patients
Stapleton, R. D., Suratt, B. T., Neff, M. J., Wurfel, M. M., Ware, L. B., RUZINSKI, J. T., Caldwell, E., Hallstrand, T. S., & Parsons, P. E. (2019) · Biomarkers · doi:10.1080/1354750x.2019.1581840 · Cited by 22
Cited by
Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M. V., McGroder, C., Stevens, J. S., Cook, J. R., Nordvig, A. S., Shalev, D., Sehrawat, T. S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01283-z · Cited by 4,862
Long covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655
Risk factors for severe and critically ill COVID‐19 patients: A review
Gao, Y., Ding, M., Dong, X., Zhang, J., Kursat Azkur, A., Azkur, D., Gan, H., Sun, Y., Fu, W., Li, W., et al. (2021) · Allergy · doi:10.1111/all.14657 · Cited by 1,402
The signal pathways and treatment of cytokine storm in COVID-19
Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 603
Lanzoni, G., Linetsky, E., Correa, D., Messinger Cayetano, S., Alvarez, R. A., Kouroupis, D., Alvarez Gil, A., Poggioli, R., Ruiz, P., Marttos, A. C., et al. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0472 · Cited by 404
Metadata
- Authors
- McElvaney, O. J., McEvoy, N. L., McElvaney, O. F., Carroll, T. P., Murphy, M. P., Dunlea, D. M., Ní Choileáin, O., Clarke, J., O’Connor, E., Hogan, G., Ryan, D., Sulaiman, I., Gunaratnam, C., Branagan, P., O’Brien, M. E., Morgan, R. K., Costello, R. W., Hurley, K., Walsh, S., de Barra, E., McNally, C., McConkey, S., Boland, F., Galvin, S., Kiernan, F., O’Rourke, J., Dwyer, R., Power, M., Geoghegan, P., Larkin, C., O’Leary, R. A., Freeman, J., Gaffney, A., Marsh, B., Curley, G. F., & McElvaney, N. G.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-09-15
- Volume
- 202
- Issue
- 6
- Pages
- 812-821
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3037768701
- Cited by
- 628
- References
- 38
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.